DrugPatentWatch Database Preview
OXYCODONE AND ACETAMINOPHEN Drug Profile
Which patents cover Oxycodone And Acetaminophen, and when can generic versions of Oxycodone And Acetaminophen launch?
Oxycodone And Acetaminophen is a drug marketed by Actavis Elizabeth, Barr, Duramed Pharms Barr, Halsey, Mallinckrodt, Mutual Pharm, Vintage Pharms, Vintage Pharms Llc, Watson Labs, Abhai Llc, Mikart Inc, Specgx Llc, Alvogen, Amneal Pharms, Amneal Pharms Ny, Anda Repository, Ascent Pharms Inc, Aurolife Pharma Llc, Elite Labs Inc, Epic Pharma Llc, Lannett Co Inc, Mayne Pharma Inc, Mikart, Nesher Pharms, Novel Labs Inc, Rhodes Pharms, Sun Pharm Inds Inc, Wes Pharma Inc, and Xiromed. and is included in forty-nine NDAs.
The generic ingredient in OXYCODONE AND ACETAMINOPHEN is acetaminophen; oxycodone hydrochloride. There are sixty-six drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.
Summary for OXYCODONE AND ACETAMINOPHEN
| US Patents: | 0 |
| Applicants: | 29 |
| NDAs: | 49 |
| Suppliers / Packagers: | 40 |
| Bulk Api Vendors: | 1 |
| Clinical Trials: | 106 |
| Patent Applications: | 6 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | OXYCODONE AND ACETAMINOPHEN at DailyMed |
Recent Clinical Trials for OXYCODONE AND ACETAMINOPHEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Northwestern University | Phase 4 |
| University of Massachusetts, Worcester | Phase 4 |
| William Beaumont Hospitals | Phase 4 |
Pharmacology for OXYCODONE AND ACETAMINOPHEN
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
Synonyms for OXYCODONE AND ACETAMINOPHEN
| 330988-72-2 |
| Acetaminophen mixture with Oxycodone |
| DTXSID10186763 |
| Magnacet |
| Oxycodone mixture with Acetaminophen |
| Primlev |
| SCHEMBL2521418 |
US Patents and Regulatory Information for OXYCODONE AND ACETAMINOPHEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nesher Pharms | OXYCODONE AND ACETAMINOPHEN | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 210079-003 | Dec 28, 2017 | AA | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Aurolife Pharma Llc | OXYCODONE AND ACETAMINOPHEN | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 201972-003 | Jul 15, 2013 | AA | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Anda Repository | OXYCODONE AND ACETAMINOPHEN | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 207834-001 | Aug 15, 2019 | AA | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
